DRUG
Bright Minds Biosciences
DRUG
DRUG
48 hedge funds and large institutions have $137M invested in Bright Minds Biosciences in 2025 Q2 according to their latest regulatory filings, with 23 funds opening new positions, 7 increasing their positions, 9 reducing their positions, and 9 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
48
Holders Change
+14
Holders Change %
+41.18%
% of All Funds
0.64%
Holding in Top 10
1
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-50%
% of All Funds
0.01%
New
23
Increased
7
Reduced
9
Closed
9
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–
Top Buyers
1 |
BlackRock
New York
|
$5.47M |
2 |
Geode Capital Management
Boston,
Massachusetts
|
$1.5M |
3 |
Janus Henderson Group
London,
United Kingdom
|
$30.2M |
4 |
Vanguard Group
Malvern,
Pennsylvania
|
$835K |
5 |
Northern Trust
Chicago,
Illinois
|
$669K |
Top Sellers
1 |
RCM
RA Capital Management
Boston,
Massachusetts
|
$0 |
2 |
Millennium Management
New York
|
$2.91M |
3 |
Walleye Capital
New York
|
$1.4M |
4 |
Goldman Sachs
New York
|
$0 |
5 |
![]()
Marshall Wace
London,
United Kingdom
|
$0 |